The DOI matches its Crossref record; 118 of the 118 references it cites were found in a registry or an index.
Type I interferons in tuberculosis: Foe and occasionally friend
Open accessAbstract
Tuberculosis remains one of the leading causes of mortality worldwide, and, despite its clinical significance, there are still significant gaps in our understanding of pathogenic and protective mechanisms triggered by Mycobacterium tuberculosis infection. Type I interferons (IFN) regulate a broad family of genes that either stimulate or inhibit immune function, having both host-protective and detrimental effects, and exhibit well-characterized antiviral activity. Transcriptional studies have uncovered a potential deleterious role for type I IFN in active tuberculosis. Since then, additional studies in human tuberculosis and experimental mouse models of M. tuberculosis infection support the concept that type I IFN promotes both bacterial expansion and disease pathogenesis. More recently, studies in a different setting have suggested a putative protective role for type I IFN. In this study, we discuss the mechanistic and contextual factors that determine the detrimental versus beneficial outcomes of type I IFN induction during M. tuberculosis infection, from human disease to experimental mouse models of tuberculosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global tuberculosis report (2014)
Gabbasova, L. A., & Who, E. R. E. (2014) · Cited by 12,702
Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
Keane, J., Gershon, S., Wise, R. P., Mirabile-Levens, E., Kasznica, J., Schwieterman, W. D., Siegel, J. N., & Braun, M. M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011110 · Cited by 3,710
Regulation of type I interferon responses
Ivashkiv, L. B., & Donlin, L. T. (2014) · Nature Reviews Immunology · doi:10.1038/nri3581 · Cited by 3,297
Type I interferons in infectious disease
McNab, F., Mayer-Barber, K., Sher, A., Wack, A., & O'Garra, A. (2015) · Nature Reviews Immunology · doi:10.1038/nri3787 · Cited by 2,780
Self-citationAn essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection.
Flynn, J. L., Chan, J., Triebold, K. J., Dalton, D. K., Stewart, T. A., & Bloom, B. R. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.6.2249 · Cited by 2,465
Flynn, J. L., & Chan, J. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.93 · Cited by 2,155
Disseminated tuberculosis in interferon gamma gene-disrupted mice.
Cooper, A. M., Dalton, D. K., Stewart, T. A., Griffin, J. P., Russell, D. G., & Orme, I. M. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.6.2243 · Cited by 1,986
An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis
Berry, M. P. R., Graham, C. M., McNab, F. W., Xu, Z., Bloch, S. A. A., Oni, T., Wilkinson, K. A., Banchereau, R., Skinner, J., Wilkinson, R. J., et al. (2010) · Nature · doi:10.1038/nature09247 · Cited by 1,898
Self-citationInterferons, interferon‐like cytokines, and their receptors
Pestka, S., Krause, C. D., & Walter, M. R. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00204.x · Cited by 1,766
Flynn, J. L., Goldstein, M. M., Chan, J., Triebold, K. J., Pfeffer, K., Lowenstein, C. J., Schrelber, R., Mak, T. W., & Bloom, B. R. (1995) · Immunity · doi:10.1016/1074-7613(95)90001-2 · Cited by 1,677
The Immune Response in Tuberculosis
O'Garra, A., Redford, P. S., McNab, F. W., Bloom, C. I., Wilkinson, R. J., & Berry, M. P. R. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095939 · Cited by 1,342
Self-citationA Mutation in the Interferon-γ –Receptor Gene and Susceptibility to Mycobacterial Infection
Newport, M. J., Huxley, C. M., Huston, S., Hawrylowicz, C. M., Oostra, B. A., Williamson, R., & Levin, M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612263352602 · Cited by 1,199
Cell-Mediated Immune Responses in Tuberculosis
Cooper, A. M. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132703 · Cited by 1,162
Type I Interferon in Systemic Lupus Erythematosus and Other Autoimmune Diseases
Banchereau, J., & Pascual, V. (2006) · Immunity · doi:10.1016/j.immuni.2006.08.010 · Cited by 963
Impairment of Mycobacterial Immunity in Human Interleukin-12 Receptor Deficiency
Altare, F., Durandy, A., Lammas, D., Emile, J.-F., Lamhamedi, S., Le Deist, F., Drysdale, P., Jouanguy, E., Döffinger, R., Bernaudin, F., et al. (1998) · Science · doi:10.1126/science.280.5368.1432 · Cited by 845
Type I interferon: friend or foe?
Trinchieri, G. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20101664 · Cited by 844
Severe Mycobacterial and Salmonella Infections in Interleukin-12 Receptor-Deficient Patients
Jong, R. D., Altare, F., Haagen, I.-A., Elferink, D. G., Boer, T. D., van Breda Vriesman, P. J. C., Kabel, P. J., Draaisma, J. M. T., van Dissel, J. T., Kroon, F. P., et al. (1998) · Science · doi:10.1126/science.280.5368.1435 · Cited by 821
A blood RNA signature for tuberculosis disease risk: a prospective cohort study
Zak, D. E., Penn-Nicholson, A., Scriba, T. J., Thompson, E., Suliman, S., Amon, L. M., Mahomed, H., Erasmus, M., Whatney, W., Hussey, G. D., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01316-1 · Cited by 780
Latent Mycobacterium tuberculosis Infection
Getahun, H., Matteelli, A., Chaisson, R. E., & Raviglione, M. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1405427 · Cited by 775
Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk
Mayer-Barber, K. D., Andrade, B. B., Oland, S. D., Amaral, E. P., Barber, D. L., Gonzales, J., Derrick, S. C., Shi, R., Kumar, N. P., Wei, W., et al. (2014) · Nature · doi:10.1038/nature13489 · Cited by 767
Self-citationLawn, S. D., & Zumla, A. I. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62173-3 · Cited by 751
Cooper, A. M., Magram, J., Ferrante, J., & Orme, I. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.1.39 · Cited by 715
Genetic variation among 129 substrains and its importance for targeted mutagenesis in mice
Simpson, E. M., Linder, C. C., Sargent, E. E., Davisson, M. T., Mobraaten, L. E., & Sharp, J. J. (1997) · Nature Genetics · doi:10.1038/ng0597-19 · Cited by 686
North, R. J., & Jung, Y.-J. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104635 · Cited by 677
Watson, R. O., Bell, S. L., MacDuff, D. A., Kimmey, J. M., Diner, E. J., Olivas, J., Vance, R. E., Stallings, C. L., Virgin, H. W., & Cox, J. S. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.05.004 · Cited by 645
Manca, C., Tsenova, L., Bergtold, A., Freeman, S., Tovey, M., Musser, J. M., Barry, C. E., Freedman, V. H., & Kaplan, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091096998 · Cited by 595
Mycobacterial Disease and Impaired IFN-γ Immunity in Humans with Inherited ISG15 Deficiency
Bogunovic, D., Byun, M., Durfee, L. A., Abhyankar, A., Sanal, O., Mansouri, D., Salem, S., Radovanovic, I., Grant, A. V., Adimi, P., et al. (2012) · Science · doi:10.1126/science.1224026 · Cited by 572
Human intracellular ISG15 prevents interferon-α/β over-amplification and auto-inflammation
Zhang, X., Bogunovic, D., Payelle-Brogard, B., Francois-Newton, V., Speer, S. D., Yuan, C., Volpi, S., Li, Z., Sanal, O., Mansouri, D., et al. (2015) · Nature · doi:10.1038/nature13801 · Cited by 558
Gautier, G., Humbert, M., Deauvieau, F., Scuiller, M., Hiscott, J., Bates, E. E. M., Trinchieri, G., Caux, C., & Garrone, P. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041964 · Cited by 537
Yan, N., & Chen, Z. J. (2012) · Nature Immunology · doi:10.1038/ni.2229 · Cited by 532
Jouanguy, E., Lamhamedi-Cherradi, S., Lammas, D., Dorman, S. E., Fondanèche, M.-C., Dupuis, S., Döffinger, R., Altare, F., Girdlestone, J., Emile, J.-F., et al. (1999) · Nature Genetics · doi:10.1038/7701 · Cited by 492
Regulation of antiviral T cell responses by type I interferons
Crouse, J., Kalinke, U., & Oxenius, A. (2015) · Nature Reviews Immunology · doi:10.1038/nri3806 · Cited by 479
Mayer-Barber, K. D., Barber, D. L., Shenderov, K., White, S. D., Wilson, M. S., Cheever, A., Kugler, D., Hieny, S., Caspar, P., Núñez, G., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0904189 · Cited by 478
Self-citationManzanillo, P. S., Shiloh, M. U., Portnoy, D. A., & Cox, J. S. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.03.007 · Cited by 473
The role of IL-10 in immune regulation during M. tuberculosis infection
Redford, P. S., Murray, P. J., & O'Garra, A. (2011) · Mucosal Immunology · doi:10.1038/mi.2011.7 · Cited by 472
Self-citationThe Yin and Yang of type I interferon activity in bacterial infection
Decker, T., Müller, M., & Stockinger, S. (2005) · Nature Reviews Immunology · doi:10.1038/nri1684 · Cited by 468
Stanley, S. A., Johndrow, J. E., Manzanillo, P., & Cox, J. S. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.5.3143 · Cited by 432
Mayer-Barber, K. D., Andrade, B. B., Barber, D. L., Hieny, S., Feng, C. G., Caspar, P., Oland, S., Gordon, S., & Sher, A. (2011) · Immunity · doi:10.1016/j.immuni.2011.12.002 · Cited by 418
Self-citationWassermann, R., Gulen, M. F., Sala, C., Perin, S. G., Lou, Y., Rybniker, J., Schmid-Burgk, J. L., Schmidt, T., Hornung, V., Cole, S. T., et al. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.05.003 · Cited by 401
Cyclic GMP-AMP Synthase Is an Innate Immune DNA Sensor for Mycobacterium tuberculosis
Collins, A. C., Cai, H., Li, T., Franco, L. H., Li, X.-D., Nair, V. R., Scharn, C. R., Stamm, C. E., Levine, B., Chen, Z. J., et al. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.05.005 · Cited by 390
Type I Interferon Suppresses Type II Interferon–Triggered Human Anti-Mycobacterial Responses
Teles, R. M. B., Graeber, T. G., Krutzik, S. R., Montoya, D., Schenk, M., Lee, D. J., Komisopoulou, E., Kelly-Scumpia, K., Chun, R., Iyer, S. S., et al. (2013) · Science · doi:10.1126/science.1233665 · Cited by 380
Diagnosis of Childhood Tuberculosis and Host RNA Expression in Africa
Anderson, S. T., Kaforou, M., Brent, A. J., Wright, V. J., Banwell, C. M., Chagaluka, G., Crampin, A. C., Dockrell, H. M., French, N., Hamilton, M. S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1303657 · Cited by 379
Kaforou, M., Wright, V. J., Oni, T., French, N., Anderson, S. T., Bangani, N., Banwell, C. M., Brent, A. J., Crampin, A. C., Dockrell, H. M., et al. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001538 · Cited by 371
Mycobacterium tuberculosis evades macrophage defenses by inhibiting plasma membrane repair
Divangahi, M., Chen, M., Gan, H., Desjardins, D., Hickman, T. T., Lee, D. M., Fortune, S., Behar, S. M., & Remold, H. G. (2009) · Nature Immunology · doi:10.1038/ni.1758 · Cited by 367
Chen, M., Divangahi, M., Gan, H., Shin, D. S. J., Hong, S., Lee, D. M., Serhan, C. N., Behar, S. M., & Remold, H. G. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080767 · Cited by 357
IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection
Flynn, J. L., Goldstein, M. M., Triebold, K. J., Sypek, J., Wolf, S., & Bloom, B. R. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.5.2515 · Cited by 324
Common patterns and disease-related signatures in tuberculosis and sarcoidosis
Maertzdorf, J., Weiner, J., Mollenkopf, H.-J., Network, T., Bauer, T., Prasse, A., Müller-Quernheim, J., Kaufmann, S. H. E., Bellinger, O., Diel, R., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121072109 · Cited by 321
The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection.
Cooper, A. M., Roberts, A. D., Rhoades, E. R., Callahan, J. E., Getzy, D. M., & Orme, I. M. (1995) · PubMed Central · Cited by 308
Human gene expression profiles of susceptibility and resistance in tuberculosis
Maertzdorf, J., Repsilber, D., Parida, S. K., Stanley, K., Roberts, T., Black, G., Walzl, G., & Kaufmann, S. H. E. (2011) · Genes & Immunity · doi:10.1038/gene.2010.51 · Cited by 304
Bloom, C. I., Graham, C. M., Berry, M. P. R., Rozakeas, F., Redford, P. S., Wang, Y., Xu, Z., Wilkinson, K. A., Wilkinson, R. J., Kendrick, Y., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070630 · Cited by 304
Self-citationManca, C., Tsenova, L., Freeman, S., Barczak, A. K., Tovey, M., Murray, P. J., Barry, C., & Kaplan, G. (2005) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2005.25.694 · Cited by 294
Antonelli, L. R. V., Gigliotti Rothfuchs, A., Gonçalves, R., Roffê, E., Cheever, A. W., Bafica, A., Salazar, A. M., Feng, C. G., & Sher, A. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40817 · Cited by 292
Self-citationPandey, A. K., Yang, Y., Jiang, Z., Fortune, S. M., Coulombe, F., Behr, M. A., Fitzgerald, K. A., Sassetti, C. M., & Kelliher, M. A. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000500 · Cited by 292
Dey, B., Dey, R. J., Cheung, L. S., Pokkali, S., Guo, H., Lee, J.-H., & Bishai, W. R. (2015) · Nature Medicine · doi:10.1038/nm.3813 · Cited by 268
Type I interferons: crucial participants in disease amplification in autoimmunity
Hall, J. C., & Rosen, A. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2009.237 · Cited by 265
Structural basis of a unique interferon-β signaling axis mediated via the receptor IFNAR1
de Weerd, N. A., Vivian, J. P., Nguyen, T. K., Mangan, N. E., Gould, J. A., Braniff, S.-J., Zaker-Tabrizi, L., Fung, K. Y., Forster, S. C., Beddoe, T., et al. (2013) · Nature Immunology · doi:10.1038/ni.2667 · Cited by 264
Ordway, D., Henao-Tamayo, M., Harton, M., Palanisamy, G., Troudt, J., Shanley, C., Basaraba, R. J., & Orme, I. M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.1.522 · Cited by 259
Scriba, T. J., Penn-Nicholson, A., Shankar, S., Hraha, T., Thompson, E. G., Sterling, D., Nemes, E., Darboe, F., Suliman, S., Amon, L. M., et al. (2017) · PLOS Pathogens · doi:10.1371/journal.ppat.1006687 · Cited by 251
Novikov, A., Cardone, M., Thompson, R., Shenderov, K., Kirschman, K. D., Mayer-Barber, K. D., Myers, T. G., Rabin, R. L., Trinchieri, G., Sher, A., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100926 · Cited by 242
Self-citationCliff, J. M., Lee, J.-S., Constantinou, N., Cho, J.-E., Clark, T. G., Ronacher, K., King, E. C., Lukey, P. T., Duncan, K., Van Helden, P. D., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis499 · Cited by 240
Jacobsen, M., Repsilber, D., Gutschmidt, A., Neher, A., Feldmann, K., Mollenkopf, H. J., Ziegler, A., & Kaufmann, S. H. E. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0157-6 · Cited by 239
Singhania, A., Verma, R., Graham, C. M., Lee, J., Tran, T., Richardson, M., Lecine, P., Leissner, P., Berry, M. P. R., Wilkinson, R. J., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04579-w · Cited by 233
Self-citationOttenhoff, T. H. M., Dass, R. H., Yang, N., Zhang, M. M., Wong, H. E. E., Sahiratmadja, E., Khor, C. C., Alisjahbana, B., van Crevel, R., Marzuki, S., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045839 · Cited by 230
Dorhoi, A., Yeremeev, V., Nouailles, G., Weiner, J., Jörg, S., Heinemann, E., Oberbeck‐Müller, D., Knaul, J. K., Vogelzang, A., Reece, S. T., et al. (2014) · European Journal of Immunology · doi:10.1002/eji.201344219 · Cited by 226
Distinct TLR- and NLR-Mediated Transcriptional Responses to an Intracellular Pathogen
Leber, J. H., Crimmins, G. T., Raghavan, S., Meyer-Morse, N. P., Cox, J. S., & Portnoy, D. A. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.0040006 · Cited by 222
Mayer-Barber, K. D., & Yan, B. (2017) · Cellular & Molecular Immunology · doi:10.1038/cmi.2016.25 · Cited by 213
Self-citationBloom, C. I., Graham, C. M., Berry, M. P. R., Wilkinson, K. A., Oni, T., Rozakeas, F., Xu, Z., Rossello-Urgell, J., Chaussabel, D., Banchereau, J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046191 · Cited by 206
Self-citationMcNab, F. W., Ewbank, J., Howes, A., Moreira-Teixeira, L., Martirosyan, A., Ghilardi, N., Saraiva, M., & O’Garra, A. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401088 · Cited by 197
Self-citationDisease-Promoting Effects of Type I Interferons in Viral, Bacterial, and Coinfections
Davidson, S., Maini, M. K., & Wack, A. (2015) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2014.0227 · Cited by 196
Type I interferonopathies: Mendelian type I interferon up-regulation
Crow, Y. J. (2015) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.10.005 · Cited by 190
Wiens, K. E., & Ernst, J. D. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1005809 · Cited by 176
Dynamic Roles of Type I and Type II IFNs in Early Infection with Mycobacterium tuberculosis
Desvignes, L., Wolf, A. J., & Ernst, J. D. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200255 · Cited by 173
Cytokine and lipid mediator networks in tuberculosis
Mayer-Barber, K. D., & Sher, A. (2015) · Immunological Reviews · doi:10.1111/imr.12249 · Cited by 167
Self-citationFunctional Correlations of Pathogenesis-Driven Gene Expression Signatures in Tuberculosis
Maertzdorf, J., Ota, M., Repsilber, D., Mollenkopf, H. J., Weiner, J., Hill, P. C., & Kaufmann, S. H. E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026938 · Cited by 167
Fortin, A., Abel, L., Casanova, J. L., & Gros, P. (2007) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.8.080706.092315 · Cited by 166
Sensing of M ycobacterium tuberculosis and consequences to both host and bacillus
Stamm, C. E., Collins, A. C., & Shiloh, M. U. (2015) · Immunological Reviews · doi:10.1111/imr.12263 · Cited by 155
Gene‐Expression Patterns in Whole Blood Identify Subjects at Risk for Recurrent Tuberculosis
Mistry, R. A., Cliff, J. M., Clayton, C. L., Beyers, N., Mohamed, Y. S., Wilson, P. A., Dockrell, H. M., Wallace, D., van Helden, P. D., Duncan, K., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/510397 · Cited by 145
Redford, P. S., Mayer-Barber, K. D., McNab, F. W., Stavropoulos, E., Wack, A., Sher, A., & O’Garra, A. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit424 · Cited by 140
Self-citationIncreased Complement C1q Level Marks Active Disease in Human Tuberculosis
Cai, Y., Yang, Q., Tang, Y., Zhang, M., Liu, H., Zhang, G., Deng, Q., Huang, J., Gao, Z., Zhou, B., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092340 · Cited by 138
Cooper, A. M., Pearl, J. E., Brooks, J. V., Ehlers, S., & Orme, I. M. (2000) · Infection and Immunity · doi:10.1128/iai.68.12.6879-6882.2000 · Cited by 135
Shah, S., Bohsali, A., Ahlbrand, S. E., Srinivasan, L., Rathinam, V. A. K., Vogel, S. N., Fitzgerald, K. A., Sutterwala, F. S., & Briken, V. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301331 · Cited by 128
Gröschel, M. I., Sayes, F., Shin, S. J., Frigui, W., Pawlik, A., Orgeur, M., Canetti, R., Honoré, N., Simeone, R., van der Werf, T. S., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.02.057 · Cited by 125
Post, F. A., Wood, R., & Pillay, G. P. (1995) · Tubercle and Lung Disease · doi:10.1016/0962-8479(95)90527-8 · Cited by 123
T Cell–Derived IL-10 Impairs Host Resistance to Mycobacterium tuberculosis Infection
Moreira-Teixeira, L., Redford, P. S., Stavropoulos, E., Ghilardi, N., Maynard, C. L., Weaver, C. T., do Rosário, A. P. F., Wu, X., Langhorne, J., & O’Garra, A. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601340 · Cited by 123
Self-citationDonovan, M. L., Schultz, T. E., Duke, T. J., & Blumenthal, A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01633 · Cited by 120
Inhibition of innate immune cytosolic surveillance by an M. tuberculosis phosphodiesterase
Dey, R. J., Dey, B., Zheng, Y., Cheung, L. S., Zhou, J., Sayre, D. A., Kumar, P., Guo, H., Lamichhane, G., Sintim, H. O., et al. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2254 · Cited by 113
Sambarey, A., Devaprasad, A., Mohan, A., Ahmed, A., Nayak, S., Swaminathan, S., D′Souza, G., Jesuraj, A., Dhar, C., Babu, S., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.12.009 · Cited by 111
Esmail, H., Lai, R., Lesosky, M., Wilkinson, K. A., Graham, C. M., Horswell, S. D., Coussens, A. K., Barry, C. E., O’Garra, A., & Wilkinson, R. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1711853115 · Cited by 110
Self-citationMoreira-Teixeira, L., Sousa, J., McNab, F. W., Torrado, E., Cardoso, F., Machado, H., Castro, F., Cardoso, V., Gaifem, J., Wu, X., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600584 · Cited by 105
Self-citationBlood transcriptomic diagnosis of pulmonary and extrapulmonary tuberculosis
Roe, J. K., Thomas, N., Gil, E., Best, K., Tsaliki, E., Morris-Jones, S. D., Stafford, S. L., Simpson, N., Witt, K. D., Chain, B., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.87238 · Cited by 100
Revised nomenclature for strain 129 mice
Festing, M. F. W., Simpson, E. M., Davisson, M. T., & Mobraaten, L. E. (1999) · Mammalian Genome · doi:10.1007/s003359901099 · Cited by 98
Joosten, S. A., Fletcher, H. A., & Ottenhoff, T. H. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073230 · Cited by 98
McNab, F. W., Ewbank, J., Rajsbaum, R., Stavropoulos, E., Մարտիրոսյան, Ա., Redford, P. S., Wu, X., Graham, C. M., Saraiva, M., Tsichlis, P. N., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300146 · Cited by 98
Self-citationB Cells Producing Type I IFN Modulate Macrophage Polarization in Tuberculosis
Bénard, A., Sakwa, I., Schierloh, P., Colom, A., Mercier, I., Tailleux, L., Jouneau, L., Boudinot, P., Saati, T. A., Lang, R., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201707-1475oc · Cited by 94
Self-citationTroegeler, A., Mercier, I., Cougoule, C., Pietretti, D., Colom, A., Duval, C., Manh, T. V., Capilla, F., Poincloux, R., Pingris, K., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1613254114 · Cited by 88
Carmona, J. A., Cruz, A., Moreira-Teixeira, L., Sousa, C., Sousa, J., Osório, N. S., Saraiva, A. L., Svenson, S. B., Källenius, G., Pedrosa, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067277 · Cited by 84
Self-citationInterfering with immunity: detrimental role of type I IFNs during infection
Stifter, S. A., & Feng, C. G. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402794 · Cited by 78
Aerosolized interferon-alpha treatment in patients with multi-drug-resistant pulmonary tuberculosis.
Giosuè, S., Casarini, M., Ameglio, F., ZANGRILLI, P., Palla, M., Altieri, A. M., & Bisetti, A. (2000) · PubMed · Cited by 74
Zhang, G., de Weerd, N. A., Stifter, S. A., Liu, L., Zhou, B., Wang, W., Zhou, Y., Ying, B., Hu, X. L., Matthews, A. Y., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02611-z · Cited by 70
Inhibition of the type I immune responses of human monocytes by IFN-α and IFN-β
de Paus, R. A., van Wengen, A., Schmidt, I., Visser, M., Verdegaal, E. M. E., van Dissel, J. T., & van de Vosse, E. (2013) · Cytokine · doi:10.1016/j.cyto.2012.12.005 · Cited by 66
Bottai, D., Frigui, W., Clark, S., Rayner, E., Zelmer, A., Andreu, N., de Jonge, M. I., Bancroft, G. J., Williams, A., Brodin, P., et al. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.03.083 · Cited by 60
The impact of ISGylation during Mycobacterium tuberculosis infection in mice
Kimmey, J. M., Campbell, J. A., Weiss, L. A., Monte, K. J., Lenschow, D. J., & Stallings, C. L. (2017) · Microbes and Infection · doi:10.1016/j.micinf.2016.12.006 · Cited by 56
Meta-analysis of host response networks identifies a common core in tuberculosis
Sambarey, A., Devaprasad, A., Baloni, P., Mishra, M., Mohan, A., Tyagi, P., Singh, A., Akshata, J. S., Sultana, R., Buggi, S., et al. (2017) · npj Systems Biology and Applications · doi:10.1038/s41540-017-0005-4 · Cited by 56
Ruangkiattikul, N., Nerlich, A. G., Abdissa, K., Lienenklaus, S., Suwandi, A., Janze, N., Laarmann, K., Spanier, J., Kalinke, U., Weiß, S., et al. (2017) · Virulence · doi:10.1080/21505594.2017.1321191 · Cited by 56
Yan, S., Shen, H., Lian, Q., Jin, W., Zhang, R., Lin, X., Gu, W., Sun, X., Meng, G., Tian, Z., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1701177 · Cited by 55
Interferon Alpha Treatment of Patients with Impaired Interferon Gamma Signaling
Bax, H. I., Freeman, A. F., Ding, L., Hsu, A. P., Marciano, B. E., Kristosturyan, E., Jancel, T., Spalding, C. D., Pechacek, J., Olivier, K. N., et al. (2013) · Journal of Clinical Immunology · doi:10.1007/s10875-013-9882-5 · Cited by 54
Dauphinee, S. M., Richer, É., Eva, M. A., McIntosh, F. A., Paquet, M., Dangoor, D., Burkart, C., Zhang, D.-E., Gruenheid, S., Gros, P., et al. (2014) · Genes and Immunity · doi:10.1038/gene.2014.17 · Cited by 51
A 380-gene meta-signature of active tuberculosis compared with healthy controls
Blankley, S., Graham, C. M., Levin, J., Turner, J., Berry, M. P. R., Bloom, C. I., Xu, Z., Pascual, V., Banchereau, J., Chaussabel, D., et al. (2016) · European Respiratory Journal · doi:10.1183/13993003.02121-2015 · Cited by 51
Self-citationDomaszewska, T., Scheuermann, L., Hahnke, K., Mollenkopf, H., Dorhoi, A., Kaufmann, S. H. E., & Weiner, J. M. (2017) · Scientific Reports · doi:10.1038/s41598-017-11812-x · Cited by 47
Ward, C. M., Jyonouchi, H., Kotenko, S. V., Smirnov, S. V., Patel, R. K., Aguila, H., McSherry, G., Dashefsky, B., & Holland, S. M. (2006) · European Journal of Pediatrics · doi:10.1007/s00431-006-0339-1 · Cited by 45
IFN-β improves BCG immunogenicity by acting on DC maturation
Giacomini, E., Remoli, M. E., Gafa, V., Pardini, M., Fattorini, L., & Coccia, E. M. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0908583 · Cited by 44
Howes, A., Taubert, C., Blankley, S., Spink, N., Wu, X., Graham, C. M., Zhao, J., Saraiva, M., Ricciardi‐Castagnoli, P., Bancroft, G. J., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501923 · Cited by 41
Self-citationGideon, H. P., Skinner, J. A., Baldwin, N. E., Flynn, J. L., & Lin, P. L. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1601138 · Cited by 40
Interferon-alpha treatment of hepatitis D induces tuberculosis exacerbation in an immigrant
Telesca, C., Angelico, M., Piccolo, P., Nosotti, L., Morrone, A., Longhi, C., Carbone, M., & Baiocchi, L. (2007) · Journal of Infection · doi:10.1016/j.jinf.2006.12.009 · Cited by 38
Kuchtey, J., Fulton, S. A., Reba, S. M., Harding, C. V., & Boom, W. H. (2006) · Immunology · doi:10.1111/j.1365-2567.2006.02337.x · Cited by 37
Rivas-Santiago, C., & Guerrero, G. G. (2017) · BioMed Research International · doi:10.1155/2017/8796760 · Cited by 25
IFN-β: A Contentious Player in Host–Pathogen Interaction in Tuberculosis
Sabir, N., Hussain, T. A., Shah, S. Z. A., Zhao, D., & Zhou, X. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122725 · Cited by 24
Zarogoulidis, P., Kioumis, I. P., Παπάνας, Ν., Manika, Κ., Kontakiotis, T., Papagianis, A., & Zarogoulidis, P. (2012) · Journal of Chemotherapy · doi:10.1179/1973947812y.0000000005 · Cited by 20
Cited by
Host-directed immunotherapy of viral and bacterial infections: past, present and future
Wallis, R. S., O’Garra, A., Sher, A., & Wack, A. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-022-00734-z · Cited by 255
Self-citationMoreira-Teixeira, L., Tabone, O., Graham, C. M., Singhania, A., Stavropoulos, E., Redford, P. S., Chakravarty, P., Priestnall, S. L., Suarez-Bonnet, A., Herbert, E., et al. (2020) · Nature Immunology · doi:10.1038/s41590-020-0610-z · Cited by 127
Self-citationPath‐seq identifies an essential mycolate remodeling program for mycobacterial host adaptation
Peterson, E. J., Bailo, R., Rothchild, A. C., Arrieta‐Ortiz, M. L., Kaur, A., Pan, M., Mai, D., Abidi, A. A., Cooper, C., Aderem, A., et al. (2019) · Molecular Systems Biology · doi:10.15252/msb.20188584 · Cited by 63
Transcriptome analysis of mouse aortae reveals multiple novel pathways regulated by aging
Gao, P., Gao, P., Choi, M., Chegireddy, K., Slivano, O. J., Zhao, J., Zhang, W., & Long, X. (2020) · Aging · doi:10.18632/aging.103652 · Cited by 21
“In accord with GO enrichment analysis, tuberculosis, which is an infectious disease closely related to type I IFN [30], was among the top enriched upregulated KEGG pathways (Figure 2B).”
Background
Metadata
- Authors
- Moreira-Teixeira, L., Mayer-Barber, K., Sher, A., & O’Garra, A.
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2018-04-17
- Volume
- 215
- Issue
- 5
- Pages
- 1273-1285
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2799364359
- Cited by
- 282
- References
- 118
- FWCI
- 17.12
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.